Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_3
2
50%
Ph phase_4
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Terminated1
Completed1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (50.0%)
Phase 42 (50.0%)

Trials by Status

terminated125%
completed125%
unknown125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_4

RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis

NCT06643780
completedphase_3

Zometa Study in Pediatric Acute Lymphoblastic Leukemia

NCT01656512
terminatedphase_4

Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer

NCT00375752
unknownphase_3

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

NCT00326820

Clinical Trials (4)

Showing 4 of 4 trials
NCT06643780Phase 4

RANK-ligand Inhibition to Combat Sarcopenia with Underlying Osteoporosis

Recruiting
NCT01656512Phase 3

Zometa Study in Pediatric Acute Lymphoblastic Leukemia

Completed
NCT00375752Phase 4

Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer

Terminated
NCT00326820Phase 3

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4